Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate.

Among dozens of new laws signed this week by Gov. Jared Polis are consumer-friendly rules making it easier to cancel services ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Weight loss drugs can be purchased online with ease, and a boom in sales exposes consumers to risk. #EuropeNews ...

The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...